Polycystic ovary syndrome, adipose tissue and metabolic syndrome

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity

Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860 · see citing works

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

(2002) · Circulation · doi:10.1161/circ.106.25.3143 · Cited by 14,092 · see citing works

Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198 · see citing works

The metabolic syndrome—a new worldwide definition

Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · see citing works

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050 · see citing works

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518 · see citing works

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)

The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138 · see citing works

Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition

Grundy, S. M., Brewer, H. B., Cleeman, J. I., Smith, S. C., & Lenfant, C. (2004) · Circulation · doi:10.1161/01.cir.0000111245.75752.c6 · Cited by 5,982 · see citing works

Leptin and the regulation of body weight in mammals

Friedman, J. M., & Halaas, J. L. (1998) · Nature · doi:10.1038/27376 · Cited by 5,405 · see citing works

Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity

Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J.-I., Hotta, K., Shimomura, I., Nakamura, T., Miyaoka, K., et al. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0255 · Cited by 4,856 · see citing works

Abdominal obesity and metabolic syndrome

Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · see citing works

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

Scherer, P. E., Williams, S. P., Fogliano, M., Baldini, G., & Lodish, H. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.45.26746 · Cited by 3,238 · see citing works

Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome

Wajchenberg, B. L. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.6.0415 · Cited by 2,961 · see citing works

Adiponectin and Adiponectin Receptors

Kadowaki, T., & Yamauchi, T. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0005 · Cited by 2,634 · see citing works

What we talk about when we talk about fat

Rosen, E. D., & Spiegelman, B. M. (2014) · Cell · doi:10.1016/j.cell.2013.12.012 · Cited by 2,373 · see citing works

AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity

Hu, E., Liang, P., & Spiegelman, B. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10697 · Cited by 2,239 · see citing works

The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report

Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132 · see citing works

Inflammatory Cytokine Concentrations Are Acutely Increased by Hyperglycemia in Humans: Role of Oxidative Stress

Esposito, K., Nappo, F., Marfella, R., Giugliano, G., Giugliano, F., Ciotola, M., Quagliaro, L., Ceriello, A., & Giugliano, D. (2002) · Circulation · doi:10.1161/01.cir.0000034509.14906.ae · Cited by 1,961 · see citing works

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications

Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947 · see citing works

A transgenic model of visceral obesity and the metabolic syndrome

Masuzaki, H., Paterson, J., Shinyama, H., Morton, N. M., Mullins, J. J., Seckl, J. R., & Flier, J. S. (2001) · Science · doi:10.1126/science.1066285 · Cited by 1,766 · see citing works

Plasma Adiponectin Levels and Risk of Myocardial Infarction in Men

Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,762 · see citing works

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women

Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743 · see citing works

Adiponectin, an Adipocyte-Derived Plasma Protein, Inhibits Endothelial NF-κB Signaling Through a cAMP-Dependent Pathway

Ouchi, N., Kihara, S., Arita, Y., Okamoto, Y., Maeda, K., Kuriyama, H., Hotta, K., Nishida, M., Takahashi, M., Muraguchi, M., et al. (2000) · Circulation · doi:10.1161/01.cir.102.11.1296 · Cited by 1,730 · see citing works

The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited

Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603 · see citing works

Comparison of the Release of Adipokines by Adipose Tissue, Adipose Tissue Matrix, and Adipocytes from Visceral and Subcutaneous Abdominal Adipose Tissues of Obese Humans

Fain, J. N., Madan, A. K., Hiler, M. L., Cheema, P. S., & Bahouth, S. W. (2004) · Endocrinology · doi:10.1210/en.2003-1336 · Cited by 1,571 · see citing works

Recombinant Leptin for Weight Loss in Obese and Lean Adults: A Randomized, Controlled, Dose-Escalation Trial

Heymsfield, S. B., Greenberg, A. S., Fujioka, K., Dixon, R. M., Kushner, R., Hunt, T., Lubina, J. A., Patane, J., Self, B., Hunt, P., et al. (1999) · JAMA · doi:10.1001/jama.282.16.1568 · Cited by 1,422 · see citing works

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257 · see citing works

Prevalence of and Risk Factors for Nonalcoholic Fatty Liver Disease: The Dionysos Nutrition and Liver Study * #

Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,250 · see citing works

Leptin-Replacement Therapy for Lipodystrophy

Oral, E. A., Simha, V., Ruiz, E., Andewelt, A., Premkumar, A., Snell, P., Wagner, A. J., DePaoli, A. M., Reitman, M. L., Taylor, S. I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012437 · Cited by 1,247 · cited 1× · see citing works

Adiponectin and Metabolic Syndrome

Matsuzawa, Y., Funahashi, T., Kihara, S., & Shimomura, I. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000099786.99623.ef · Cited by 1,203 · see citing works

Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance

Caro, J. F., Kolaczynski, J. W., Nyce, M. R., Ohannesian, J. P., Opentanova, I., Goldman, W. H., Lynn, R. B., Zhang, P.-L., Sinha, M. K., & Considine, R. V. (1996) · The Lancet · doi:10.1016/s0140-6736(96)03173-x · Cited by 1,175 · see citing works

Obesity Wars

Flier, J. S. (2004) · Cell · doi:10.1016/s0092-8674(03)01081-x · Cited by 1,105 · see citing works

Pro-inflammatory cytokines and adipose tissue

Coppack, S. W. (2001) · Proceedings of The Nutrition Society · doi:10.1079/pns2001110 · Cited by 1,008 · see citing works

Improvement in Endocrine and Ovarian Function during Dietary Treatment of Obese Women with Polycystic Ovary Syndrome

Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921 · see citing works

Isolation and Characterization of GBP28, a Novel Gelatin-Binding Protein Purified from Human Plasma

Nakano, Y., Tobe, T., Choi-Miura, N.-H., Mazda, T., & Tomita, M. (1996) · The Journal of Biochemistry · doi:10.1093/oxfordjournals.jbchem.a021483 · Cited by 915 · see citing works

Obesity and the polycystic ovary syndrome

Gambineri, A., Pelusi, C., Vicennati, V., Pagotto, U., & Pasquali, R. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0801994 · Cited by 838 · see citing works

Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS)

Wallace, A. M., McMahon, A. D., Packard, C. J., Kelly, A., Shepherd, J., Gaw, A., & Sattar, N. A. (2001) · Circulation · doi:10.1161/hc5001.101061 · Cited by 821 · see citing works

A Direct Effect of Hyperinsulinemia on Serum Sex Hormone-Binding Globulin Levels in Obese Women with the Polycystic Ovary Syndrome*

NESTLER, J. E., POWERS, L. P., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., RITTMASTER, R. S., CLORE, J. N., & BLACKARD, W. G. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-83 · Cited by 815 · see citing works

Prevalence and Predictors of the Metabolic Syndrome in Women with Polycystic Ovary Syndrome

Ehrmann, D. A., Liljenquist, D. R., Kasza, K., Azziz, R., Legro, R. S., & Ghazzi, M. N. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1329 · Cited by 703 · see citing works

Release of Interleukins and Other Inflammatory Cytokines by Human Adipose Tissue Is Enhanced in Obesity and Primarily due to the Nonfat Cells

Fain, J. N. (2006) · Vitamins and hormones · doi:10.1016/s0083-6729(06)74018-3 · Cited by 679 · see citing works

The role of SOCS-3 in leptin signaling and leptin resistance

Bjørbæk, C., El-Haschimi, K., Frantz, J. D., & Flier, J. S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30059 · Cited by 639 · see citing works

Adipose Tissue-Derived Factors: Impact on Health and Disease

Trujillo, M. E., & Scherer, P. E. (2006) · Endocrine Reviews · doi:10.1210/er.2006-0033 · Cited by 611 · see citing works

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

DeUgarte, C. M., Bartolucci, A. A., & Azziz, R. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.11.070 · Cited by 589 · see citing works

Induction of Adipocyte Complement-Related Protein of 30 Kilodaltons by PPARγ Agonists: A Potential Mechanism of Insulin Sensitization

Combs, T. P., Wagner, J. A., Berger, J. P., Doebber, T. W., Wang, W., Zhang, B. B., Tanen, M. R. L., Berg, A. H., O’Rahilly, S., Savage, D. B., et al. (2002) · Endocrinology · doi:10.1210/endo.143.3.8662 · Cited by 565 · see citing works

Leptin Signaling in the Central Nervous System and the Periphery

Bjørbæk, C. (2004) · Recent Progress in Hormone Research · doi:10.1210/rp.59.1.305 · Cited by 557 · see citing works

Regulation of adipocytokines and insulin resistance

Faßhauer, M., & Paschke, R. (2003) · Diabetologia · doi:10.1007/s00125-003-1228-z · Cited by 543 · see citing works

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-α

Ruan, H., & Lodish, H. F. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00052-2 · Cited by 541 · see citing works

Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults

Licinio, J., Caglayan, S., Ozata, M., Yildiz, B. O., de Miranda, P. B., O'Kirwan, F., Whitby, R., Liang, L., Cohen, P., Bhasin, S., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308767101 · Cited by 505 · see citing works

Polycystic Ovary Syndrome as a Form of FunctionalOvarian Hyperandrogenism Due to Dysregulation ofAndrogen Secretion*

EHRMAN, D. A., Barnes, R. B., & Rosenfield, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 502 · see citing works

Leptin and atherosclerosis

Bełtowski, J. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.03.003 · Cited by 484 · see citing works

Genetic, hormonal and metabolic aspects of PCOS: an update

De Leo, V., Musacchio, M. C., Cappelli, V., Massaro, M. G., Morgante, G., & Petraglia, F. (2016) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-016-0173-x · Cited by 484 · see citing works

Adipocytokines: leptin—the classical, resistin—the controversical, adiponectin—the promising, and more to come

Koerner, A., Kratzsch, J., & Kiess, W. (2005) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2005.07.008 · Cited by 471 · see citing works

Tissue-specific changes in peripheral cortisol metabolism in obese women: increased adipose 11beta-hydroxysteroid dehydrogenase type 1 activity.

Rask, E., Walker, B., Söderberg, S., Livingstone, D., Eliasson, M., Johnson, O., Andrew, R., & Olsson, T. (2002) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem.87.7.8661 · Cited by 467 · see citing works

Gender Differences of Adiponectin Levels Develop during the Progression of Puberty and Are Related to Serum Androgen Levels

Böttner, A., Kratzsch, J., Müller, G., Kapellen, T. M., Blüher, S., Keller, E., Blüher, M., & Kieß, W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0303 · Cited by 453 · see citing works

Adolescent Girls with Polycystic Ovary Syndrome Have an Increased Risk of the Metabolic Syndrome Associated with Increasing Androgen Levels Independent of Obesity and Insulin Resistance

Coviello, A. D., Legro, R. S., & Dunaif, A. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1666 · Cited by 446 · see citing works

Diagnosis of Polycystic Ovarian Syndrome: The Rotterdam Criteria Are Premature

Azziz, R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2153 · Cited by 434 · see citing works

Nonalcoholic Fatty Liver Disease

Clark, J. M., & Diehl, A. M. (2003) · JAMA · doi:10.1001/jama.289.22.3000 · Cited by 431 · see citing works

Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies

Hull, M. G. R. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709023610 · Cited by 423 · see citing works

Testosterone Selectively Reduces the High Molecular Weight Form of Adiponectin by Inhibiting Its Secretion from Adipocytes

Xu, A., Chan, K. W., Hoo, R. L. C., Wang, Y., Tan, K. C. B., Zhang, J., Chen, B., Lam, M. C., Tse, C. A., Cooper, G. J. S., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414231200 · Cited by 418 · see citing works

Low Dose Leptin Administration Reverses Effects of Sustained Weight-Reduction on Energy Expenditure and Circulating Concentrations of Thyroid Hormones

Rosenbaum, M., Murphy, E. M., Heymsfield, S. B., Matthews, D. E., & Leibel, R. L. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.5.2391 · Cited by 407 · see citing works

The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome

Nelson, V. L., Qin, K.-N., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8088 · Cited by 405 · see citing works

Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion

Ehrmann, D. A. (1995) · Endocrine Reviews · doi:10.1210/er.16.3.322 · Cited by 403 · see citing works

Association of the T-G Polymorphism in Adiponectin (Exon 2) With Obesity and Insulin Sensitivity

Stumvoll, M., Tschritter, O., Fritsche, A., Staiger, H., Renn, W., Weisser, M., Machicao, F., & Häring, H. (2002) · Diabetes · doi:10.2337/diabetes.51.1.37 · Cited by 371 · see citing works

The emerging role of adipokines as mediators of inflammation and immune responses

Lago, F., Diéguez, C., Gómez-Reino, J. J., & Gualillo, O. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.04.007 · Cited by 370 · see citing works

Growth Hormone, Body Composition, and Aging

Rudman, D. R. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb04195.x · Cited by 363 · see citing works

Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome

Norman, R. J., Masters, L., Milner, C. R., Wang, J. X., & Davies, M. J. (2001) · Human Reproduction · doi:10.1093/humrep/16.9.1995 · Cited by 341 · see citing works

Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS)

Dunaif, A., Wu, X., Lee, A., & Diamanti-Kandarakis, E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.2.e392 · Cited by 337 · see citing works

Cellular mechanisms of insulin resistance in polycystic ovarian syndrome

Ciaraldi, T. P. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.2.577 · Cited by 336 · see citing works

Non-alcoholic fatty liver disease and the metabolic syndrome: An update

Rector, R. S., Thyfault, J. P., Wei, Y., & Ibdah, J. A. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.185 · Cited by 335 · see citing works

Changes in Glucose Tolerance over Time in Women with Polycystic Ovary Syndrome: A Controlled Study

Legro, R. S., Gnatuk, C. L., Kunselman, A. R., & Dunaif, A. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1843 · Cited by 308 · see citing works

Serum Levels of Tumor Necrosis Factor-α Are Increased in Obese Patients with Noninsulin-Dependent Diabetes Mellitus1

Katsuki, A., Sumida, Y., Murashima, S., Murata, K., Takarada, Y., Ito, K., Fujii, M., Tsuchihashi, K., Goto, H., Nakatani, K., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4618 · Cited by 301 · see citing works

Pathophysiology and types of dyslipidemia in PCOS

Diamanti‐Kandarakis, E., Papavassiliou, A. G., Kandarakis, S., & Chrousos, G. P. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.07.004 · Cited by 301 · see citing works

A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia.

Weyer, C., Hanson, R. L., Tataranni, P. A., Bogardus, C., & Pratley, R. E. (2000) · Diabetes · doi:10.2337/diabetes.49.12.2094 · Cited by 296 · see citing works

Polycystic ovarian syndrome: Pathophysiology, molecular aspects and clinical implications

Diamanti-Kandarakis, E. (2008) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399408000598 · Cited by 294 · see citing works

Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome

Kirchengast, S. (2001) · Human Reproduction · doi:10.1093/humrep/16.6.1255 · Cited by 291 · see citing works

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

Leo, V. D., Marca, A. L., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 289 · see citing works

Young Men With High-Normal Blood Pressure Have Lower Serum Adiponectin, Smaller LDL Size, and Higher Elevated Heart Rate Than Those With Optimal Blood Pressure

Kazumi, T., Kawaguchi, A. T., Sakai, K., Hirano, T., & Yoshino, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.971 · Cited by 274 · see citing works

Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis

Toulis, K. A., Goulis, D. G., Farmakiotis, D., Georgopoulos, N. A., Katsikis, I., Tarlatzis, B. C., Papadimas, I., & Panidis, D. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp006 · Cited by 262 · see citing works

Hypoadiponectinemia as a Predictor for the Development of Hypertension

Chow, W.-S., Cheung, B. M. Y., Tso, A. W. K., Xu, A., Wat, N. M. S., Fong, C. H.-Y., Ong, L. H. Y., Tam, S., Tan, K. C. B., Janus, E. D., et al. (2007) · Hypertension · doi:10.1161/hypertensionaha.107.086835 · Cited by 262 · see citing works

Cardioprotection by Adiponectin

Ouchi, N., Shibata, R., & Walsh, K. X. (2006) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2006.03.001 · Cited by 257 · see citing works

Adipose Tissue Intracrinology: Potential Importance of Local Androgen/Estrogen Metabolism in the Regulation of Adiposity

Bélanger, C., Luu-The, V., Dupont, P., & Tchernof, A. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-38265 · Cited by 246 · see citing works

Obesity

Björntorp, P. A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04503-0 · Cited by 234 · see citing works

Local and Systemic Impact of Transcriptional Up-Regulation of 11β-Hydroxysteroid Dehydrogenase Type 1 in Adipose Tissue in Human Obesity

Wake, D. J., Rask, E., Livingstone, D. E. W., Söderberg, S., Olsson, T., & Walker, B. R. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030286 · Cited by 231 · see citing works

Role of leptin in blood pressure regulation and arterial hypertension

Bełtowski, J. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000222743.06584.66 · Cited by 214 · see citing works

Polycystic ovary syndrome

Schaffrinna, M. G. (1991) · Journal of Adolescent Health · doi:10.1016/0197-0070(91)90048-q · Cited by 214 · see citing works

Nonalcoholic Steatohepatitis and Nonalcoholic Fatty Liver Disease in Young Women with Polycystic Ovary Syndrome

Setji, T. L., Holland, N. D., Sanders, L. L., Pereira, K. C., Diehl, A. M., & Brown, A. J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2774 · Cited by 210 · see citing works

Regulation of Adiponectin Expression in Human Adipocytes: Effects of Adiposity, Glucocorticoids, and Tumor Necrosis Factor α

Degawa‐Yamauchi, M., Moss, K. A., Bovenkerk, J. E., Shankar, S. S., Morrison, C. L., Lelliott, C. J., Vidal‐Puig, A., Jones, R., & Considine, R. V. (2005) · Obesity Research · doi:10.1038/oby.2005.74 · Cited by 204 · see citing works

Impaired Activation of AMP-Kinase and Fatty Acid Oxidation by Globular Adiponectin in Cultured Human Skeletal Muscle of Obese Type 2 Diabetics

Chen, M. B., McAinch, A. J., Macaulay, S. L., Castelli, L. A., O’Brien, P. E., Dixon, J. B., Cameron‐Smith, D., Kemp, B. E., & Steinberg, G. R. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1980 · Cited by 200 · see citing works

Elevated serum levels of tumor necrosis factor alpha in normal-weight women with polycystic ovary syndrome

González, F., Thusu, K., Abdel-Rahman, E., Prabhala, A., Tomani, M., & Dandona, P. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90100-2 · Cited by 199 · see citing works

Differential Activity of the Cytochrome P450 17α-Hydroxylase and Steroidogenic Acute Regulatory Protein Gene Promoters in Normal and Polycystic Ovary Syndrome Theca Cells1

Wickenheisser, J. K., Quinn, P. G., Nelson-DeGrave, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.6.6631 · Cited by 192 · see citing works

Prolactin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue

Nilsson, L., Binart, N., Bohlooly-Y, M., Bramnert, M., Egecioglu, E., Kindblom, J., Kelly, P. A., Kopchick, J. J., Ormandy, C. J., Ling, C., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.04.026 · Cited by 191 · see citing works

Downregulation of electron transport chain genes in visceral adipose tissue in type 2 diabetes independent of obesity and possibly involving tumor necrosis factor-α.

Dahlman, I., Forsgren, M., Sjögren, A., Nordström, E. A., Kaaman, M., Näslund, E., Attersand, A., & Arner, P. (2006) · Diabetes · doi:10.2337/db05-1421 · Cited by 184 · see citing works

Serum testosterone levels decrease in middle age in women with the polycystic ovary syndrome

Winters, S. J., Talbott, E. O., Guzick, D. S., Zborowski, J. V., & McHugh-Pemu, K. P. (2000) · Fertility and Sterility · doi:10.1016/s0015-0282(99)00641-x · Cited by 182 · see citing works

Global adiposity rather than abnormal regional fat distribution characterizes women with polycystic ovary syndrome

Barber, T. M., Golding, S. J., Alvey, C., Wass, J. A. H., Karpe, F., Franks, S., & McCarthy, M. I. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2117 · Cited by 179 · see citing works

A Unique Defect in the Regulation of Visceral Fat Cell Lipolysis in the Polycystic Ovary Syndrome as an Early Link to Insulin Resistance

Ek, I., Arner, P., Rydén, M., Holm, C., Thörne, A., Hoffstedt, J., & Wahrenberg, H. (2002) · Diabetes · doi:10.2337/diabetes.51.2.484 · Cited by 174 · see citing works

Diagnosis, epidemiology, and genetics of the polycystic ovary syndrome

Goodarzi, M. O., & Azziz, R. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.005 · Cited by 170 · see citing works

Polycystic Ovary Syndrome

Pasquali, R., & Gambineri, A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.014 · Cited by 170 · see citing works

Abdominal Visceral Fat and Fasting Insulin Are Important Predictors of 24-Hour GH Release Independent of Age, Gender, and Other Physiological Factors

Clasey, J. L., WELTMAN, A. L., Patrie, J., Weltman, J. Y., Pezzoli, S. S., Bouchard, C., Thorner, M. O., & Hartman, M. L. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7731 · Cited by 166 · see citing works

Glucocorticoids Down-Regulate Glucose Uptake Capacity and Insulin-Signaling Proteins in Omental But Not Subcutaneous Human Adipocytes

Lundgren, M., Burén, J., Ruge, T., Myrnäs, T., & Eriksson, J. W. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031157 · Cited by 163 · see citing works

11β-Hydroxysteroid Dehydrogenase Type 1 Activity in Lean and Obese Males with Type 2 Diabetes Mellitus

Valsamakis, G., Anwar, A., Tomlinson, J., Shackleton, C. H. L., McTernan, P. G., Chetty, R., Wood, P. J., Banerjee, A. K., Holder, G., Barnett, A. H., et al. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032240 · Cited by 160 · see citing works

Beta-adrenoceptor expression in human fat cells from different regions.

Arner, P., Hellström, L., Wahrenberg, H., & Brönnegård, M. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114880 · Cited by 155 · see citing works

Evidence for a functional β3‐adrenoceptor in man

Lönnqvist, F., Krief, S., Strosberg, A. D., Nyberg, SS., Emorine, L. J., & Arner, P. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13902.x · Cited by 150 · see citing works

Free fatty acids FFA a link between obesity and insulin resistance

Boden, G. H. (1998) · Frontiers in bioscience · doi:10.2741/a272 · Cited by 149 · see citing works

Prevalence of Polycystic Ovary Syndrome Among Premenopausal Women With Type 2 Diabetes

Peppard, H. R., Marfori, J., Iuorno, M. J., & Nestler, J. E. (2001) · Diabetes Care · doi:10.2337/diacare.24.6.1050 · Cited by 147 · see citing works

Adipose tissue is a regulated source of interleukin-10

Juge-Aubry, C. E., Somm, E., Pernin, A., Alizadeh, N., Giusti, V., Dayer, J.-M., & Meier, C. A. (2005) · Cytokine · doi:10.1016/j.cyto.2004.10.017 · Cited by 144 · see citing works

Leptin Induces C-Reactive Protein Expression in Vascular Endothelial Cells

Singh, P., Hoffmann, M., Wolk, R. A., Shamsuzzaman, A., & Somers, V. K. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.148353 · Cited by 139 · see citing works

Evaluation of Adverse Outcome in Young Women with Polycystic Ovary Syndrome<i>Versus</i>Matched, Reference Controls: A Retrospective, Observational Study

Morgan, C. L., Jenkins-Jones, S., Currie, C. J., & Rees, D. A. (2012) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2012-1690 · Cited by 136 · see citing works

The adrenal and polycystic ovary syndrome

Yıldız, B. O., & Azziz, R. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9054-0 · Cited by 135 · see citing works

11β-hydroxysteroid dehydrogenase type 1 as a modulator of glucocorticoid action: from metabolism to memory

Seckl, J. R., & Walker, B. R. (2004) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2004.09.007 · Cited by 134 · see citing works

The serine phosphorylation hypothesis of polycystic ovary syndrome: a unifying mechanism for hyperandrogenemia and insulin resistance

Bremer, A. A., & Miller, W. L. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.02.091 · Cited by 131 · see citing works

Lower-Body Adiposity and Metabolic Protection in Postmenopausal Women

Pelt, R. E. V., Jankowski, C. M., Gozansky, W. S., Schwartz, R. S., & Kohrt, W. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1764 · Cited by 131 · see citing works

Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome

Spranger, J., Möhlig, M., Wegewitz, U. E., Ristow, M., Pfeiffer, A. F. H., Schill, T., Schlösser, H. W., Brabant, G. E., & Schöfl, C. (2004) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02159.x · Cited by 130 · see citing works

Polycystic Ovary Syndrome Is Associated with Tissue-Specific Differences in Insulin Resistance

Ciaraldi, T. P., Aroda, V. R., Mudaliar, S. R. D., Chang, R. J., & Henry, R. R. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1492 · Cited by 128 · see citing works

Diagnosis of hyperandrogenism: clinical criteria

Yıldız, B. O. (2006) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2006.02.004 · Cited by 126 · see citing works

Prevalence of endocrine diseases and abnormal glucose tolerance tests in 340 caucasian premenopausal women with hirsutism as the referral diagnosis

Glintborg, D., Henriksen, J. E., Andersen, M., Hagen, C., Hangaard, J., Rasmussen, P. E., Schousboe, K., & Hermann, A. P. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.06.040 · Cited by 126 · see citing works

Insulin Sensitization for Girls with Precocious Pubarche and with Risk for Polycystic Ovary Syndrome: Effects of Prepubertal Initiation and Postpubertal Discontinuation of Metformin Treatment

Ibáñez, L., Valls, C., Marcos, M. V., Ong, K. K., Dunger, D. B., & de Zegher, F. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0463 · Cited by 123 · see citing works

Studies of the nature of 17-hydroxyprogesterone hyperresonsiveness to gonadotropin-releasing hormone agonist challenge in functional ovarian hyperandrogenism

Rosenfield, R. L., Barnes, R. B., & Ehrmann, D. A. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.6.7989476 · Cited by 119 · see citing works

Endocrine Aspects of Obesity

Glass, A. R. (1989) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)30696-4 · Cited by 118 · see citing works

Diagnosis, phenotype, and prevalence of polycystic ovary syndrome.

Carmina, E., & Azziz, R. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.03.012 · Cited by 117 · see citing works

Indices of low-grade inflammation in polycystic ovary syndrome

DIAMANTI‐KANDARAKIS, E., PATERAKIS, T., & KANDARAKIS, H. A. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1365.015 · Cited by 112 · see citing works

An association between non‐alcoholic fatty liver disease and polycystic ovarian syndrome

Brzozowska, M. M., Ostapowicz, G., & Weltman, M. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05740.x · Cited by 110 · see citing works

Association between plasma adiponectin levels and unstable coronary syndromes

Wolk, R. A., Berger, P. B., Lennon, R. J., Brilakis, E. S., Davison, D. E., & Somers, V. K. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl361 · Cited by 106 · see citing works

High Serum Tumor Necrosis Factor-Alpha Levels in Women with Polycystic Ovary Syndrome: A Meta-Analysis

Gao, L., Gu, Y., & Yin, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164021 · Cited by 95 · see citing works

Effect of weight loss on coronary circulation and adiponectin levels in obese women

Coppola, A., Marfella, R., Coppola, L., Tagliamonte, E., Fontana, D., Liguori, E., Cirillo, T., Cafiero, M., Natale, S., & Astarita, C. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.12.087 · Cited by 92 · see citing works

The genetics of adiponectin

Vasseur, F., Leprêtre, F., Lacquemant, C., & Froguel, P. (2003) · Current Diabetes Reports · doi:10.1007/s11892-003-0039-4 · Cited by 90 · see citing works

Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome

Comim, F. V., Hardy, K., & Franks, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080416 · Cited by 89 · see citing works

Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome

Cupisti, S., Kajaia, N., Dittrich, R., Duezenli, H., Beckmann, M. W., & Mueller, A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0515 · Cited by 86 · see citing works

Serum resistin and adiponectin levels in women with polycystic ovary syndrome

Yılmaz, M., Bukan, N. C., Demirci, H., Ozturk, C. S., Kan, E., Ayvaz, G., & Arslan, M. (2009) · Gynecological Endocrinology · doi:10.1080/09513590802653833 · Cited by 84 · see citing works

Metabolic Effects and Pharmacokinetics of a Growth Hormone Pulse in Healthy Adults: Relation to Age, Sex, and Body Composition

Vahl, N., Møller, N., Lauritzen, T., Christiansen, J. S., & Jørgensen, J. O. L. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.11.4388 · Cited by 84 · see citing works

Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice

Bauche, I. B., Ait-El-Mkadem, S., Rezsöhazy, R., Funahashi, T., Maeda, N., Miranda, L., & Brichard, S. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.05.033 · Cited by 79 · see citing works

Plasma monocyte chemoattractant protein‐1 (MCP‐1) and macrophage inflammatory protein‐1α are increased in patients with polycystic ovary syndrome (PCOS) and associated with adiposity, but unaffected by pioglitazone treatment

Glintborg, D., Andersen, M., Richelsen, B., & Bruun, J. M. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2009.03523.x · Cited by 78 · see citing works

Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and I year after adenomectomy

Brummer, R. J., LÖNNS, L., Kvist, H., Grangård, U., Bengtsson, B. Å., & Sjöström, L. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00762.x · Cited by 78 · see citing works

Cytokine secretion by human adipocytes is differentially regulated by adiponectin, AICAR, and troglitazone

Sell, H., Dietze‐Schroeder, D., Eckardt, K., & Eckel, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.010 · Cited by 78 · see citing works

Relationships between leptin and C-reactive protein with cardiovascular disease in the adult general population

Romero-Corral, A., Sierra-Johnson, J., Lopez-Jimenez, F., Thomas, R. J., Singh, P., Hoffmann, M., Okcay, A., Korinek, J., Wolk, R., & Somers, V. K. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1218 · Cited by 77 · see citing works

Ultrasound in polycystic ovary syndrome the measuring of ovarian stroma and relationship with circulating androgens: results of a multicentric study

Fulghesu, A. M., Angioni, S. L., Frau, E., Belosi, C., Apa, R., Mioni, R., Xamin, N., Capobianco, G., Dessole, S., Fruzzetti, F., et al. (2007) · Human Reproduction · doi:10.1093/humrep/dem202 · Cited by 75 · see citing works

Effect of long-term rhGH administration in GH-deficient adults on fat cell epinephrine response

Beauville, M., Harant, I., Crampes, F., Rivière, D., Tauber, M., Tauber, J.-P., & Garrigues, M. (1992) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1992.263.3.e467 · Cited by 74 · see citing works

Metformin Increases the Novel Adipokine Cartonectin/CTRP3 in Women With Polycystic Ovary Syndrome

Tan, B. K., Chen, J., Hu, J., Amar, O., Mattu, H. S., Adya, R., Patel, V. C., Ramanjaneya, M., Lehnert, H., & Randeva, H. S. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2227 · Cited by 72 · see citing works

Adiponectin Levels Associated with the Development of Hypertension: A Prospective Study

Imatoh, T., Miyazaki, M., Momose, Y., Tanihara, S., & Hiroshi, U. N. E. (2008) · Hypertension Research · doi:10.1291/hypres.31.229 · Cited by 67 · see citing works

Android subcutaneous adipose tissue topography in lean and obese women suffering from PCOS: Comparison with type 2 diabetic women

Horejsi, R., Möller, R., Rackl, S., Giuliani, A., Freytag, U., Crailsheim, K., Sudi, K. M., & Tafeit, E. (2003) · American Journal of Physical Anthropology · doi:10.1002/ajpa.10364 · Cited by 67 · see citing works

A systematic review of GLP-1 agonists on the metabolic syndrome in women with polycystic ovaries

Niafar, M., Pourafkari, L., Porhomayon, J., & Nader, N. (2016) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-015-3976-7 · Cited by 66 · see citing works

Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome

Tan, B. K., Chen, J., Digby, J. E., Keay, S. D., Kennedy, C. R., & Randeva, H. S. (2006) · Diabetologia · doi:10.1007/s00125-006-0419-9 · Cited by 64 · see citing works

Visfatin and leptin levels in women with polycystic ovaries undergoing ovarian stimulation

Plati, E., Kouskouni, E. E., Malamitsi‐Puchner, A., Boutsikou, M., Kaparos, G., & Baka, S. G. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.055 · Cited by 64 · see citing works

The impact of different doses of medroxyprogesterone acetate on mood symptoms in sequential hormonal therapy

Björn, I., Bixo, M., Nöjd, K. S., Collberg, P., Nyberg, S., Poromaa, I. S., & Bäckström, T. C. (2002) · Gynecological Endocrinology · doi:10.1080/gye.16.1.1.8 · Cited by 64 · see citing works

Neuromodulation in Polycystic Ovary Syndrome

Kalro, B. N., Loucks, T. L., & Berga, S. L. (2001) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(05)70184-4 · Cited by 60 · see citing works

Is the polycystic ovary syndrome associated with chronic inflammation per se?

Olszanecka‐Glinianowicz, M., Banaś, M., Zahorska‐Markiewicz, B., Janowska, J., Kocełak, P., Madej, P., & Klimek, K. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2006.10.037 · Cited by 59 · see citing works

Low Circulating Adiponectin Levels in Women with Polycystic Ovary Syndrome: An Updated Meta-Analysis

Li, S., Huang, X., Zhong, H., Peng, Q., Chen, S., Xie, Y., Qin, X., & Qin, A. (2014) · Tumor Biology · doi:10.1007/s13277-013-1595-0 · Cited by 58 · see citing works

Polycystic ovaries in pre and post‐menopausal women

Birdsall, M. A., & Farquhar, C. M. (1996) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1996.676498.x · Cited by 56 · see citing works

Growth hormone, menopause and ageing: no definite evidence for 'rejuvenation' with growth hormone

Fanciulli, G., Delitala, A., & Delitala, G. (2009) · Human Reproduction Update · doi:10.1093/humupd/dmp005 · Cited by 56 · see citing works

POLYCYSTIC OVARY SYNDROME

Legro, R. S. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70075-x · Cited by 56 · see citing works

Genetic and environmental aspect of polycystic ovary syndrome

Carmina, E. (2003) · Journal of Endocrinological Investigation · doi:10.1007/bf03345266 · Cited by 54 · see citing works

In overweight/obese but not in normal-weight women, polycystic ovary syndrome is associated with elevated liver enzymes compared to controls

Economou, F., Xyrafis, X., Livadas, S., Androulakis, I. I., Argyrakopoulou, G., Christakou, C. D., Kandaraki, E., Palioura, E., & Diamanti‐Kandarakis, E. (2009) · HORMONES · doi:10.14310/horm.2002.1236 · Cited by 51 · see citing works

Isoforms of 11β-hydroxysteroid dehydrogenase in human granulosa-lutein cells

Michael, A. E., Evagelatou, M., Norgate, D. P., Clarke, R. J., Antoniw, J. W., Stedman, B., Brennan, A., Welsby, R., Bujalska, I. J., Stewart, P. M., et al. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00118-4 · Cited by 51 · see citing works

Elevated serum TNF-alpha levels in normal-weight women with polycystic ovaries or the polycystic ovary syndrome.

Sayın, N. C., Güçer, F., Balkanlı-Kaplan, P., Yuce, M. A., Çiftçi, Ş., Küçük, M., & Yardım, T. (2003) · PubMed · Cited by 49 · see citing works

Thyroid Hormones, Metabolic Syndrome and Its Components

Delitala, A., Fanciulli, G., Pes, G. M., Maioli, M., & Delitala, G. (2017) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530317666170320105221 · Cited by 47 · see citing works

Leptin and adiponectin in the female life course

Lecke, S. B., Morsch, D. M., & Spritzer, P. M. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011000500001 · Cited by 47 · see citing works

Leptin and adiponectin in the female life course

Lecke, S. B., Morsch, D. M., & Spritzer, P. M. (2011) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2011007500035 · Cited by 45 · see citing works

Pioglitazone Treatment Increases Spontaneous Growth Hormone (GH) Secretion and Stimulated GH Levels in Polycystic Ovary Syndrome

Glintborg, D., Støving, R. K., Hagen, C., Hermann, A. P., Frystyk, J., Veldhuis, J. D., Flyvbjerg, A., & Andersen, M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0615 · Cited by 43 · see citing works

Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome

Pangaribuan, B., Yusuf, I., Mansyur, M., & Wijaya, A. (2011) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018811423770 · Cited by 41 · see citing works

Plasma levels of C-reactive protein, leptin and glycosaminoglycans during spontaneous menstrual cycle: differences between ovulatory and anovulatory cycles

Capobianco, G., Muro, P. D., Cherchi, G. M., Formato, M., Lepedda, A. J., Cigliano, A., Zinellu, E., Dessole, F., Gordini, L., & Dessole, S. (2010) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-010-1432-2 · Cited by 39 · see citing works

Screening and diagnosis of prediabetes: where are we headed?

Alberti, K. G. M. M. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00764.x · Cited by 36 · see citing works

Leptin, soluble interleukin-6 receptor, C-reactive protein and soluble vascular cell adhesion molecule-1 levels in human coronary atherosclerotic plaque

Karaduman, M., Öktenli, Ç., Muşabak, U., Şengül, A., Yeşilova, Z., Cingoz, F. O., Olgun, A., Sanisoğlu, S. Y., Baysan, O., Yildiz, O., et al. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03025.x · Cited by 35 · see citing works

Prevalence of polycystic ovarian changes and polycystic ovary syndrome in premenopausal women with treated type 2 diabetes mellitus

Keleştimur, F., Ünlühızarcı, K., Baybuga, H., Atmaca, H., Bayram, F., & Şahin, Y. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.01.019 · Cited by 35 · see citing works

Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome

Arikan, Ş., Bahçeci, M., Tuzcu, A., Kale, E., & Gökalp, D. (2009) · Gynecological Endocrinology · doi:10.3109/09513590903247816 · Cited by 34 · see citing works

Presence of metabolic risk factors in non-obese PCOS sisters: Evidence of heritability of insulin resistance

Diamanti‐Kandarakis, E., Alexandraki, K., Bergiele, A. T., KANDARAKIS, H. A., Mastorakos, G. P., & Aessopos, A. (2004) · Journal of Endocrinological Investigation · doi:10.1007/bf03347535 · Cited by 33 · see citing works

Déficit de testosterona, síndrome metabólico y diabetes mellitus

Fernández-Miró, M., Chillarón, J. J., & Pedro‐Botet, J. (2015) · Medicina Clínica · doi:10.1016/j.medcli.2015.06.020 · Cited by 33 · see citing works

Serum adiponectin and resistin levels in patients with polycystic ovarian syndrome and their clinical implications

Wang, Y., Xie, X.-M., & Zhu, W.-J. (2010) · Journal of Huazhong University of Science and Technology [Medical Sciences] · doi:10.1007/s11596-010-0556-8 · Cited by 29 · see citing works

Full‐length visfatin levels are associated with inflammation in women with polycystic ovary syndrome

Lajunen, T. K., Purhonen, A., Haapea, M., Ruokonen, A., Puukka, K. S., Hartikainen, A., Savolainen, M. J., Morin-Papunen, L. C., Tapanainen, J. S., Franks, S., et al. (2011) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2011.02586.x · Cited by 28 · see citing works

Agouti/Melanocortin Interactions with Leptin Pathways in Obesity

Zemel, M. B., & Xue, B. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1998.tb01764.x · Cited by 28 · see citing works

Polycystic ovary syndrome is not associated with genetic variants that mark risk of type 2 diabetes

Saxena, R., & Welt, C. K. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0383-4 · Cited by 27 · see citing works

Association between adipose tissue expression and serum levels of leptin and adiponectin in women with polycystic ovary syndrome

Lecke, S. B., Morsch, D. M., & Spritzer, P. M. (2013) · Genetics and Molecular Research · doi:10.4238/2013.february.28.16 · Cited by 25 · see citing works

Serum visfatin, vascular endothelial growth factor and matrix metalloproteinase-9 in women with polycystic ovary syndrome

Dambala, K., Vavilis, D., Bili, E., Goulis, D. G., & Tarlatzis, B. C. (2017) · Gynecological Endocrinology · doi:10.1080/09513590.2017.1296425 · Cited by 25 · see citing works

Adiponectin represents an independent risk factor for hypertension in middle aged Korean women.

Lee, H., Lee, M., & Joung, H. (2007) · PubMed · Cited by 23 · see citing works

Low Adiponectin Level in Young Normotensive Men with a Family History of Essential Hypertension

Furuhashi, M., Ura, N., Higashiura, K., Miyazaki, Y., MURAKAMI, H., Hyakukoku, M., & Shimamoto, K. (2005) · Hypertension Research · doi:10.1291/hypres.28.141 · Cited by 19 · see citing works

Polycystic ovary syndrome in type 2 diabetes: does it predict a more severe phenotype?

Sim, S. Y. T., Chin, S. L., Tan, J., Brown, S. J., Cussons, A. J., & Stuckey, B. G. A. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.06.040 · Cited by 19 · see citing works

Human adipocyte volumes: Maximum size, and correlation to weight index in maturity onset-diabetes

Leonhardt, W., Markolf Hanefeld, E., Schneider, H., & Haller, H. (1972) · Diabetologia · doi:10.1007/bf01225573 · Cited by 18 · see citing works

Testosterone deficiency, metabolic syndrome and diabetes mellitus

Fernández-Miró, M., Chillarón, J. J., & Pedro‐Botet, J. (2016) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2015.06.002 · Cited by 18 · see citing works

Evaluation of tumor necrosis factor alpha production in ex vivo short term cultured whole blood from women with polycystic ovary syndrome.

Araya, A. V., Aguirre, A., Romero, C., Miranda, C., Molina, M. C., & Ferreira, A. (2002) · PubMed · Cited by 16 · see citing works

Common Genetic Aspects Between Polycystic Ovary Syndrome and Diabetes Mellitus

Mendoza, N. (2011) · Current Diabetes Reviews · doi:10.2174/157339911797579142 · Cited by 11 · see citing works

Adipokines and soluble cell adhesion molecules in insulin resistant and non-insulin resistant women with polycystic ovary syndrome

Koleva, D. I., Orbetzova, M. M., Nikolova, J. G., & Tyutyundzhiev, S. B. (2016) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2016.1190760 · Cited by 10 · see citing works

Prevalence of Polycystic Ovary Syndrome in Women with Type 2 Diabetes in Kerman, Iran

Mirzaei, F., & Kazemi, N. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0015 · Cited by 7 · see citing works

Influence of Leptin, Androgens and Insulin Sensitivity on Increased GH Response to Clonidine in Lean Patients with Polycystic Ovary Syndrome

Spritzer, P. M., Comim, F. V., Capp, E., & Dávila, A. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861173 · Cited by 6 · see citing works

Sex Steroid Biosynthesis in White Adipose Tissue

Meseguer, A., Puche, C., & Cabero, A. (2002) · Hormone and Metabolic Research · doi:10.1055/s-2002-38249 · Cited by 1 · see citing works

[Mutagenic effects of gamma-rays on plasmid DNA in Escherichia coli].

Kalinin, V. L., Suslova, I. N., & Suslov, A. V. (1984) · PubMed · Cited by 1 · see citing works

Untitled work

Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7

Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy

Patel, S. (2018) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2018.04.008 · Cited by 605 · see citing works

Polycystic Ovarian Syndrome: Correlation Between Hyperandrogenism, Insulin Resistance and Obesity.

Zeng, X., Xie, Y.-J., Liu, Y.-T., Long, S.-L., & Mo, Z.-C. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.11.003 · Cited by 525 · see citing works

Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing

Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445 · see citing works

Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing

Gantenbein, K. V., & Kanaka-Gantenbein, C. (2021) · Nutrients · doi:10.3390/nu13061951 · Cited by 288 · see citing works

Polycystic ovary syndrome throughout a woman’s life

Group of interest in Reproductive Endocrinology (GIER) of the Spanish Fertility Society (SEF), Bellver, J., Rodríguez-Tabernero, L., Robles, A., Muñoz, E., Martínez, F., Landeras, J., García-Velasco, J., Fontes, J., Álvarez, M., et al. (2018) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-017-1047-7 · Cited by 180 · see citing works

Endocrine disrupting chemical Bisphenol A and its potential effects on female health

Kawa, I. A., Masood, A., Fatima, Q., Mir, S. A., Jeelani, H., Manzoor, S., & Rashid, F. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.03.031 · Cited by 167 · see citing works

A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota

Depboylu, G. Y., & Akdevelıoğlu, Y. (2019) · Journal of the American College of Nutrition · doi:10.1080/07315724.2019.1657515 · Cited by 161 · see citing works

The pharmacological management of metabolic syndrome

Larsen, J. R., Dima, L., Correll, C. U., & Manu, P. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2018.1429910 · Cited by 117 · see citing works

DNA methylation in the pathogenesis of polycystic ovary syndrome

Vázquez-Martínez, E. R., Gómez-Viais, Y. I., García-Gómez, E., Reyes-Mayoral, C., Reyes-Muñoz, E., Camacho‐Arroyo, I., & Cerbón, M. A. (2019) · Reproduction · doi:10.1530/rep-18-0449 · Cited by 107 · see citing works

Life Modifications and PCOS: Old Story But New Tales

Gu, Y., Zhou, G., Zhou, F., Wu, Q., Ma, C., Zhang, Y., Ding, J., & Hua, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.808898 · Cited by 104 · see citing works

The effects of flaxseed supplementation on metabolic status in women with polycystic ovary syndrome: a randomized open-labeled controlled clinical trial

Haidari, F., Banaei-Jahromi, N., Zakerkish, M., & Angali, K. A. (2020) · Nutrition Journal · doi:10.1186/s12937-020-0524-5 · Cited by 92 · see citing works

Role of exercise training in polycystic ovary syndrome: a systematic review and meta-analysis

Benham, J. L., Yamamoto, J. M., Friedenreich, C. M., Rabi, D. M., & Sigal, R. J. (2018) · Clinical Obesity · doi:10.1111/cob.12258 · Cited by 85 · see citing works

Thyroid function and thyroid disorders during pregnancy: a review and care pathway

Delitala, A., Capobianco, G., Cherchi, P. L., Dessole, S., & Delitala, G. (2018) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-018-5018-8 · Cited by 74 · see citing works

Metabolic hormones are integral regulators of female reproductive health and function

Athar, F., Karmani, M., & Templeman, N. M. (2023) · Bioscience Reports · doi:10.1042/bsr20231916 · Cited by 76 · see citing works

A review on critical appraisal and pathogenesis of polycystic ovarian syndrome

Hajam, Y. A., Rather, H., Neelam, Kumar, R., Basheer, M., & Reshi, M. S. (2024) · Endocrine and Metabolic Science · doi:10.1016/j.endmts.2024.100162 · Cited by 72 · see citing works

Exercise training and reproductive outcomes in women with polycystic ovary syndrome: A pilot randomized controlled trial

Benham, J. L., Booth, J. E., Corenblum, B., Doucette, S. P., Friedenreich, C. M., Rabi, D. M., & Sigal, R. J. (2021) · Clinical Endocrinology · doi:10.1111/cen.14452 · Cited by 63 · see citing works

Novel insights into the synergistic effects of selenium nanoparticles and metformin treatment of letrozole - induced polycystic ovarian syndrome: targeting PI3K/Akt signalling pathway, redox status and mitochondrial dysfunction in ovarian tissue

Rabah, H. M., Mohamed, D. A., Mariah, R. A., El‐Khalik, S. R. A., Khattab, H. A., AbuoHashish, N. A., Abdelsattar, A. M., Raslan, M. A., Farghal, E. E., & Eltokhy, A. K. (2023) · Redox Report · doi:10.1080/13510002.2022.2160569 · Cited by 62 · see citing works

Dietary Intake, Eating Behavior, Physical Activity, and Quality of Life in Infertile Women with PCOS and Obesity Compared with Non-PCOS Obese Controls

Wang, Z., Groen, H., Cantineau, A. E., van Elten, T. M., Karsten, M. D. A., van Oers, A. M., Mol, B. W., Roseboom, T. J., & Hoek, A. (2021) · Nutrients · doi:10.3390/nu13103526 · Cited by 52 · see citing works

Effects of Royal jelly on metabolic variables in diabetes mellitus: A systematic review

Maleki, V., Vayghan, H. J., Saleh‐Ghadimi, S., Adibian, M., Kheirouri, S., & Alizadeh, M. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2018.12.022 · Cited by 53 · see citing works

Levels of the neuropeptide phoenixin-14 and its receptor GRP173 in the hypothalamus, ovary and periovarian adipose tissue in rat model of polycystic ovary syndrome

Kalamon, N., Błaszczyk, K., Szlaga, A., Billert, M., Skrzypski, M., Pawlicki, P., Górowska-Wójtowicz, E., Balak, M. K. –., Błasiak, A., & Rak, A. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.101 · Cited by 52 · see citing works

Circulating levels of Meteorin-like protein in polycystic ovary syndrome: A case-control study

Fouani, F. Z., Fadaei, R., Moradi, N., Zandieh, Z., Ansaripour, S., Yekaninejad, M. S., Vatannejad, A., & Mahmoudi, M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231943 · Cited by 50 · see citing works

Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review

Carvalho, L. M. L., dos Reis, F. M., Cândido, A. L., Nunes, F. F. C., Ferreira, C. N., & Gomes, K. B. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0026 · Cited by 46 · see citing works

Why does Polycystic Ovary Syndrome (PCOS) Need Long-term Management?

Ruan, X., Li, M., & Mueck, A. O. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612825666190130104922 · Cited by 43 · see citing works

The Role of Peptide Hormones Discovered in the 21st Century in the Regulation of Adipose Tissue Functions

Kolodziejski, P. A., Pruszyńska‐Oszmałek, E., Wojciechowicz, T., Sassek, M., Leciejewska, N., Jasaszwili, M., Billert, M., Małek, E., Szczepankiewicz, D., Misiewicz-Mielnik, M., et al. (2021) · Genes · doi:10.3390/genes12050756 · Cited by 43 · see citing works

Polycystic ovary syndrome associated with increased adiposity interferes with serum levels of TNF-alpha and IL-6 differently from leptin and adiponectin

Cardoso, N. S., Ribeiro, V. B., Dutra, S. G. V., Ferriani, R. A., Gastaldi, A. C., de Araújo, J. E., & de Souza, H. C. D. (2020) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000197 · Cited by 39 · see citing works

Abdominal Obesity in Women with Polycystic Ovary Syndrome and Its Relationship with Diet, Physical Activity and Insulin Resistance: A Pilot Study

Jurczewska, J., Ostrowska, J., Chełchowska, M., Panczyk, M., Rudnicka, E., Kucharski, M., Smolarczyk, R., & Szostak-Węgierek, D. (2023) · Nutrients · doi:10.3390/nu15163652 · Cited by 37 · see citing works

Deregulation of WNT2/FZD3/β-catenin pathway compromises the estrogen synthesis in cumulus cells from patients with polycystic ovary syndrome

Qiao, G., Dong, B., Zhu, C.-J., Yan, C., & Chen, B. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.07.057 · Cited by 36 · see citing works

The Effect of Interleukin-6 (IL-6), Interleukin-11 (IL-11), Signal Transducer and Activator of Transcription 3 (STAT3), and AKT Signaling on Adipocyte Proliferation in a Rat Model of Polycystic Ovary Syndrome

Zhuang, Z., Pan, X., Zhao, K., Gao, W., Liu, J., Deng, T., & Qin, W. (2019) · Medical Science Monitor · doi:10.12659/msm.916385 · Cited by 30 · see citing works

Overweight and high serum total cholesterol were risk factors for the outcome of IVF/ICSI cycles in PCOS patients and a PCOS-specific predictive model of live birth rate was established

Gao, L., Li, M., Wang, Y., Zeng, Z., Xie, Y., Liu, G., Li, J., Zhang, B., Liang, X., Wei, L., et al. (2020) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01209-5 · Cited by 36 · see citing works

Cardiometabolic biomarkers in women with polycystic ovary syndrome

van der Ham, K., Louwers, Y. V., & Laven, J. S. E. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.03.008 · Cited by 39 · see citing works

Changes in Serum Cytokines Throughout Pregnancy in Women With Polycystic Ovary Syndrome

Stokkeland, L. M. T., Giskeødegård, G. F., Ryssdal, M., Jarmund, A. H., Steinkjer, B., Madssen, T. S., Stafne, S. N., Stridsklev, S., Løvvik, T. S., Iversen, A., et al. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab684 · Cited by 34 · see citing works

The Antiobesity Effect of GLP-1 Receptor Agonists Alone or in Combination with Metformin in Overweight /Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis

Lyu, X., Lyu, T., Wang, X., Zhu, H., Pan, H., Wang, L., Yang, H., & Gong, F. (2021) · International Journal of Endocrinology · doi:10.1155/2021/6616693 · Cited by 33 · see citing works

The effectiveness of metformin, oral contraceptives, and lifestyle modification in improving the metabolism of overweight women with polycystic ovary syndrome: a network meta-analysis

Wang, A., Mo, T., Li, Q., Shen, C., & Liu, M. (2019) · Endocrine · doi:10.1007/s12020-019-01860-w · Cited by 28 · see citing works

Serum spexin, adiponectin and leptin levels in polycystic ovarian syndrome in association with FTO gene polymorphism

Beyazıt, F., Hiz, M. M., Türkön, H., & Unsal, M. A. (2021) · Ginekologia Polska · doi:10.5603/gp.a2020.0176 · Cited by 28 · see citing works

Association between the food security status and dietary patterns with polycystic ovary syndrome (PCOS) in overweight and obese Iranian women: a case-control study

Badri-Fariman, M., Naeini, A. A., Mirzaei, K., Moeini, A., Hosseini, M., Bagheri, S. E., & Daneshi‐Maskooni, M. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00890-1 · Cited by 29 · see citing works

Histomorphological Changes in a Rat Model of Polycystic Ovary Syndrome and the Contribution of Stevia Leaf Extract in Modulating the Ovarian Fibrosis, VEGF, and TGF-β Immunoexpressions: Comparison with Metformin

Morsi, A. A., Mersal, E. A., Farrag, A. R. H., Abdelmoneim, A. M., Abdelmenem, A. M., & Salim, M. S. (2022) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.21-00081 · Cited by 28 · see citing works

The impact of lipid accumulation product (LAP) and visceral adiposity index (VAI) on clinical, hormonal and metabolic parameters in lean women with polycystic ovary syndrome

İlhan, G. A., Yıldızhan, B., & Pekin, T. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1519794 · Cited by 27 · see citing works

Incretin Hormone Secretion in Women with Polycystic Ovary Syndrome: Roles of Obesity, Insulin Sensitivity and Treatment with Metformin and GLP-1s

Etrusco, A., Mikuš, M., D’Amato, A., Barra, F., Planinić, P., Goluža, T., Buzzaccarini, G., Marušić, J., Tešanović, M., & Laganà, A. S. (2024) · Biomedicines · doi:10.3390/biomedicines12030653 · Cited by 27 · see citing works

Pathophysiological changes in experimental polycystic ovary syndrome in female albino rats: Using either hemin or L ‐arginine

Ragy, M. M., Abdel‐Hamid, H. A., & Toni, N. D. M. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27757 · Cited by 27 · see citing works

The role of insulin-like growth factor 2 mRNA binding proteins in female reproductive pathophysiology

Xu, X. L., Shen, H.-R., Zhang, J., & Li, X. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00960-z · Cited by 26 · see citing works

Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An Update

Profili, N. I., Castelli, R., Gidaro, A., Manetti, R., Maioli, M., Petrillo, M., Capobianco, G., & Delitala, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030698 · Cited by 24 · see citing works

Acetate restores hypothalamic-adipose kisspeptin status in a rat model of PCOS by suppression of NLRP3 immunoreactivity

Olaniyi, K. S., Areloegbe, S. E. J., & Oyeleke, M. B. (2022) · Endocrine · doi:10.1007/s12020-022-03191-9 · Cited by 23 · see citing works

Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome

Mansour, A., Noori, M., Hakemi, M. S., Haghgooyan, Z., Mohajeri‐Tehrani, M. R., Mirahmad, M., & Sajjadi‐Jazi, S. M. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01733-y · Cited by 21 · see citing works

Predictive factors for live birth after in vitro maturation of oocytes in women with polycystic ovary syndrome

Tannus, S., Hatırnaz, Ş., Tan, J., Ata, B., Tan, S. L., Hatırnaz, E. S., Pektas, M. K., & Dahan, M. H. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4561-z · Cited by 21 · see citing works

Risk of hospitalization for early onset of cardiovascular disease among infertile women: a register-based cohort study

Bungum, A. B., Glazer, C. H., Arendt, L. H., Schmidt, L., Pinborg, A. B., Bonde, J. P., & Tøttenborg, S. S. (2019) · Human Reproduction · doi:10.1093/humrep/dez154 · Cited by 21 · see citing works

Associations Between Asthma and Polycystic Ovary Syndrome: Current Perspectives

Xu, Y., Zhou, Z., Pan, J., & Huang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936948 · Cited by 19 · see citing works

Spexin role in human granulosa cells physiology and PCOS: expression and negative impact on steroidogenesis and proliferation

Kurowska, P., Dawid, M., Oprocha, J., Respekta, N., Serra, L., Estienne, A., Pawlicki, P., Kotula‐Balak, M., Guérif, F., Dupont, J., et al. (2023) · Biology of Reproduction · doi:10.1093/biolre/ioad108 · Cited by 19 · see citing works

Chromium supplements in health and disease

Costello, R. B., Dwyer, J. T., & Merkel, J. M. (2019) · Elsevier eBooks · doi:10.1016/b978-0-444-64121-2.00007-6 · Cited by 19 · see citing works

Potential roles of carnitine in patients with polycystic ovary syndrome: a systematic review

Maleki, V., Vayghan, H. J., Kashani, A., Moradi, F., Vajdi, M., Kheirouri, S., & Alizadeh, M. (2019) · Gynecological Endocrinology · doi:10.1080/09513590.2019.1576616 · Cited by 19 · see citing works

Physical and Mental Health Consequences of Obesity in Women

Weschenfelder, J., Bentley, J., & Himmerich, H. (2018) · InTech eBooks · doi:10.5772/intechopen.73674 · Cited by 19 · see citing works

Evaluation of the relationship between serum ferritin and insulin resistance and visceral adiposity index (VAI) in women with polycystic ovary syndrome

Gökcen, B. B., Akdevelıoğlu, Y., Canan, S., & Bozkurt, N. (2020) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-020-00980-x · Cited by 17 · see citing works

Clinical guidelines «Polycystic Ovary Syndrome»

Adamyan, L. V., Andreeva, E. N., Absatarova, Y. S., Grigoryan, O. R., Dedov, I. I., Mel'nichenko, G. A., Сутурина, Л. В., Филиппов, О. С., Sheremetyeva, E. V., Евгеньевна, Ч. Г., et al. (2022) · Problems of Endocrinology · doi:10.14341/probl12874 · Cited by 22 · see citing works

Effect of sumac powder on clinical symptoms, hyperandrogenism, inflammation, blood glucose, lipid profiles in women with polycystic ovary syndrome: A double‐blind randomized clinical trial

Afandak, F., Aryaeian, N., Kashanian, M., Janani, L., Namizadeh, T., Karimi, M. Y., & Morvaridi, M. (2023) · Phytotherapy Research · doi:10.1002/ptr.7744 · Cited by 17 · see citing works

Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone

Adeyanju, O. A., Falodun, T. O., Fabunmi, O. A., Olatunji, L. A., & Soladoye, A. O. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108742 · Cited by 17 · see citing works

Preconceptional, Gestational, and Lactational Exposure to an Unconventional Oil and Gas Chemical Mixture Alters Energy Expenditure in Adult Female Mice

Balise, V. D., Cornelius-Green, J. N., Kassotis, C. D., Rector, R. S., Thyfault, J. P., & Nagel, S. C. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00323 · Cited by 17 · see citing works

Shared postulations between bipolar disorder and polycystic ovary syndrome pathologies

Dai, W., Liu, J., Qiu, Y., Teng, Z., Li, S., Huang, J., Xiang, H., Tang, H., Wang, B., Chen, J., et al. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2021.110498 · Cited by 15 · see citing works

Is ovarian volume a good predictor to determine metabolic syndrome development in polycystic ovary patients

Sipahi, M., Tokgöz, V. Y., Keskin, Ö., Atasever, M., Menteşe, A., & Demir, S. (2019) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2018.1522530 · Cited by 16 · see citing works

Serum asprosin levels are increased and associated with insulin resistance in patients with polycystic ovary syndrome: A retrospective case-control study

Zhu, L., & Wang, L. (2023) · Medicine · doi:10.1097/md.0000000000033526 · Cited by 15 · see citing works

Associations between testosterone and metabolic syndrome in depressed and non‐depressed older men and women

de Wit, A. D., Giltay, E., de Boer, M. D., Bosker, F., van der Mast, R., Comijs, H., Voshaar, R. O., & Schoevers, R. (2019) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5040 · Cited by 12 · see citing works

Pathogenesis and treatment of obesity-related polycystic ovary syndrome

Ouyang, X., Zhou, Q., Tang, H., & Li, L. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01817-w · Cited by 15 · see citing works

Association of increased levels of omentin‐1 and carotid intima‐media thickness with early signs of cardiovascular risk in patients with polycystic ovary syndrome: A prospective case control study

Tosun, Ş. A., GÜRBÜZ, T., Çebi, A., Tosun, A., Gökmen, O., & Usta, M. (2021) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.15077 · Cited by 14 · see citing works

Body Fat Distribution and Female Infertility: a Cross-Sectional Analysis Among US Women

Wang, X., Zhu, R., Han, H., & 梅津, 敬. (2023) · Reproductive Sciences · doi:10.1007/s43032-023-01280-2 · Cited by 14 · see citing works

The Role of GnRH Receptor Autoantibodies in Polycystic Ovary Syndrome

Kem, D. C., Li, H., Yu, X., Weedin, E. A., Reynolds, A. C., Forsythe, E., Beel, M., Fischer, H., Hines, B., Guo, Y., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa078 · Cited by 17 · see citing works

Biomediators in Polycystic Ovary Syndrome and Cardiovascular Risk

Pandurevic, S., Μacut, D., Fanelli, F., Pagotto, U., & Gambineri, A. (2021) · Biomolecules · doi:10.3390/biom11091350 · Cited by 14 · see citing works

Therapy of obesity in women with PCOS using GLP-1 analogues — benefits and limitations [Terapia otyłości u kobiet z PCOS przy zastosowaniu analogów GLP-1 — korzyści i ograniczenia]

Baranowska-Bik, A. (2022) · Endokrynologia Polska · doi:10.5603/ep.a2022.0047 · Cited by 17 · see citing works

Can polyunsaturated fatty acids regulate Polycystic Ovary Syndrome via TGF-β signalling?

Prabhu, Y. D., & Gopalakrishnan, A. V. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119416 · Cited by 13 · see citing works

Deciphering the interplay between oxidative stress and inflammation in polycystic ovary syndrome: outcome of a case-control study

Padder, K. A., Jahan, N., Yousuf, M., Shah, I. A., Bhat, G. A., Khurshid, R., Zargar, M. H., & Ganie, M. A. (2025) · Journal of Ovarian Research · doi:10.1186/s13048-025-01734-y · Cited by 12 · see citing works

Chemical Characterization and Ameliorating Effect of Centratherum anthelminticum Extract against Polycystic Ovary Syndrome in Wistar Rats

Shoaib, M., Saleem, A., Zeb, A., Khan, M. I., & Akhtar, M. F. (2023) · International Journal of Endocrinology · doi:10.1155/2023/4978562 · Cited by 12 · see citing works

Metabolic characteristics of obese patients with polycystic ovarian syndrome: a meta-analysis

Pan, X. (2023) · Gynecological Endocrinology · doi:10.1080/09513590.2023.2239934 · Cited by 13 · see citing works

Flaxseed intervention and reproductive endocrine profiles in patients with polycystic ovary syndrome: an open-labeled randomized controlled clinical trial

Najdgholami, Z., Sedgi, F. M., Ghalishourani, S. S., Feyzpour, M., & Rahimlou, M. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1531762 · Cited by 12 · see citing works

Metabolic compromise in women with PCOS: earlier than expected

Lana, M. B. P., Demayo, S., Giannone, L., Nolting, M., D'Isa, E., Servetti, V., Rolo, G., Gutierrez, G., & Jarlip, M. (2020) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.66.9.1225 · Cited by 12 · see citing works

Relationship Between Genetic Polymorphisms in Cell Cycle Regulatory Gene TP53 and Polycystic Ovarian Syndrome: A Case–Control Study and In Silico Analyses

Biglari-Zadeh, G., Sargazi, S., Mohammadi, M., Ghasemi, M., Majidpour, M., Saravani, R., & Mirinejad, S. (2023) · Biochemical Genetics · doi:10.1007/s10528-023-10349-1 · Cited by 11 · see citing works

Regenerative Medicine for Polycystic Ovary Syndrome: Stem Cell-Based Therapies and Brown Adipose Tissue Activation

Karam, M., Najjar, H., El-Sabban, M. E., Hamadé, A., & Najjar, F. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10505-5 · Cited by 10 · see citing works

Polycyclic aromatic hydrocarbons in human granulosa cells: first in vivo presence and positive correlation with body mass index and in vitro ovarian cell steroidogenesis regulation

Kurowska, P., Berthet, L., Ramé, C., Węgiel, M., Maślanka, A., Guérif, F., Froment, P., Rak, A., & Dupont, J. (2024) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2024.104611 · Cited by 10 · see citing works

Evaluation of angiopoietin-like protein 3 (ANGPTL3) levels in polycystic ovary syndrome

Vatannejad, A., Salimi, F., Moradi, N., Fouani, F. Z., Zandieh, Z., Ansaripour, S., Sadeghi, A., & Fadaei, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118595 · Cited by 11 · see citing works

Risk of cardiocerebrovascular diseases is increased in Korean women with polycystic ovary syndrome: a nationwide cohort study

Ryu, K.-J., Park, H., Kim, M. S., Jeong, H. G., & Kim, T. (2024) · Scientific Reports · doi:10.1038/s41598-023-50650-y · Cited by 10 · see citing works

Lifestyle intervention towards Mediterranean Diet, physical activity adherence and anthropometric parameters in normal weight women with Polycystic Ovary Syndrome or Hashimoto’s Thyroiditis – preliminary study

Kamińska-Skrzyńska, W., Wiśniewska, K., Okręglicka, K., Pazura, I., & Nitsch-Osuch, A. S. (2023) · Annals of Agricultural and Environmental Medicine · doi:10.26444/aaem/159156 · Cited by 9 · see citing works

Circulating chemerin levels in women with polycystic ovary syndrome: a meta-analysis

Wang, X., Zhang, Q., Zhang, L., Wei, W., Liu, L., Li, B., Zhang, L., Zhang, Y., Hui, Y., & Ye, L. (2021) · Gynecological Endocrinology · doi:10.1080/09513590.2021.1963431 · Cited by 9 · see citing works

The Role of Different Methods in Defining Cardiometabolic Risk and Metabolic Syndrome in Women with Polycystic Ovary Syndrome

BİÇER, N. Ç., Ermiş, A. A., & Baş, D. (2023) · Life · doi:10.3390/life13101959 · Cited by 8 · see citing works

Unraveling intestinal microbiota’s dominance in polycystic ovary syndrome pathogenesis over vaginal microbiota

Yu, X., Li, X., & Yang, H. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1364097 · Cited by 8 · see citing works

Combined oral contraceptive use and obesity in women with polycystic ovary syndrome. A meta-analysis of randomized clinical trials

de Medeiros, S. F., Soares, J. M., de Medeiros, M. A. S., Yamamoto, A. K. L. W., de Medeiros, C. L. W., Carvalho, A. B. D. S., Yamamoto, M. M. W., & Baracat, E. C. (2024) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-024-07637-5 · Cited by 8 · see citing works

Effect of green coffee supplementation on androgens level in women with polycystic ovary syndrome: A Randomized Clinical Trial

Mousavi, A., Saedisomeolia, A., Yekaninejad, M. S., Ildarabadi, A., Meshkani, M., & Dastjerdi, M. V. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100298 · Cited by 8 · see citing works

Long noncoding RNAs as a piece of polycystic ovary syndrome puzzle

Abolghasemi, M., & Mahjoub, S. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06196-1 · Cited by 8 · see citing works

DNA methylation of the androgen receptor gene promoter in the granulosa cells of polycystic ovary syndrome patients

Desmawati, Febri, R. R., Hestiantoro, A., & Asmarinah, A. (2018) · Journal of Physics Conference Series · doi:10.1088/1742-6596/1073/3/032078 · Cited by 6 · see citing works

PPARγ—A Factor Linking Metabolically Unhealthy Obesity with Placental Pathologies

Kwiatkowski, S., Kajdy, A., Stefanska, K. A., Bednarek-Jędrzejek, M., Dzidek, S., Tousty, P., Sokołowska, M., & Kwiatkowska, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222313167 · Cited by 6 · see citing works

Pathogenic or Therapeutic: The Mediating Role of Gut Microbiota in Non-Communicable Diseases

Bu, F., Yao, X., Lü, Z., Yuan, X., Chen, C., Li, L., Li, Y., Jiang, F., Zhu, L., Shi, G., et al. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.906349 · Cited by 6 · see citing works

Causal relationships between metabolic syndrome, plasma metabolites, and female reproductive diseases: insights from a two-step mendelian randomization approach

Li, L., Ma, J., Sun, N., Hu, P., Lin, Y., & Zhang, Q. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-00955-8 · Cited by 5 · see citing works

Determination of Neurodegeneration in Polycystic Ovary Syndrome with Retinal Segmentation Analysis

Sırakaya, E., Sırakaya, H. A., Vural, E., Duru, Z., & Aksoy, H. (2020) · Current Eye Research · doi:10.1080/02713683.2020.1842460 · Cited by 5 · see citing works

CYP17A1 (rs74357) polymorphism and polycystic ovary syndrome risk: a systemic review and meta-analysis.

Rezgoune, M. L., Khour, D. E., Bendaoud, H., & Chellat, D. (2023) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v94i4.14229 · Cited by 8 · see citing works

Identification of potential diagnostic genes for atherosclerosis in women with polycystic ovary syndrome

Luo, Y., Zhou, Y., Jiang, H., Zhu, Q., Lv, Q., Zhang, X., Gu, R., Yan, B., Li, W., Zhu, Y., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-69065-4 · Cited by 5 · see citing works

Effect of microecological preparation supplementation on woman with polycystic ovary syndrome

Zhang, H., Wen, W., Shen, J., & Wei, L. (2018) · Medicine · doi:10.1097/md.0000000000013040 · Cited by 5 · see citing works

Comparative Meta-analysis of Adipose Tissue Transcriptomics Data in PCOS Patients and Healthy Control Women

Saedi, S., Panahi, R., Orak, N., & Shirazi, M. R. J. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01145-0 · Cited by 5 · see citing works

Acetate abates adipose-ovarian endocrinometabolic disturbance in experimentally induced polycystic ovarian syndrome

Olaniyi, K. S., Areloegbe, S. E. J., & Shah, M. Z. U. H. (2024) · Steroids · doi:10.1016/j.steroids.2024.109554 · Cited by 4 · see citing works

Evaluation of ultrasonographic approaches aimed at determining distinct abdominal adipose tissue depots

da Silva, N. F., Pinho, C. P. S., & Diniz, A. D. S. (2023) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000584 · Cited by 4 · see citing works

R-Spondin1 and tumor necrosis factor-alpha in infertile women with polycystic ovary syndrome: relationships with insulin resistance and other parameters

GÜRBÜZ, T., Gökmen, O., MADENLİ, A. A., & Dilbaz, B. (2023) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1210721 · Cited by 4 · see citing works

Effects of green coffee supplementation on paraoxonase-1 activity and malondialdehyde levels in Iranian women with polycystic ovary syndrome: a randomized clinical trial

Ildarabadi, A., Dastjerdi, M. V., Ghorbanpour, M., Mousavi, A., Meshkani, M., Yekaninejad, M. S., & Saedisomeolia, A. (2024) · Osong Public Health and Research Perspectives · doi:10.24171/j.phrp.2024.0187 · Cited by 4 · see citing works

Intrinsic abnormalities of adipose tissue and adipose tissue dysfunction in PCOS

Spritzer, P. M., dos Santos, B. R., Fighera, T. M., Marchesan, L. B., & Lecke, S. B. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-823045-9.00005-5 · Cited by 4 · see citing works

Enoxacin ameliorates polycystic ovary syndrome by promoting the browning of white adipose tissue and restoring gut dysbiosis

Zhu, W., Fu, L., Xu, C., Peng, K., Liu, Y., Tang, H., Huang, Y., & Yang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.978019 · Cited by 4 · see citing works

Anti-Müllerian hormone has limited ability to predict fecundability in Chinese women: a preconception cohort study

Qiu, W., Luo, K., Lu, Y., Zhao, J., Wang, Y., Yang, H., Sun, Y. W., & Zhang, J. (2022) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2022.02.014 · Cited by 4 · see citing works

Aerobic physical training impact on adipokines in women with polycystic ovary syndrome – Effects of body fat percentage

de Souza, H. C. D., Philbois, S. V., Facioli, T. D. P., Ferriani, R. A., & Gastaldi, A. C. (2022) · Archives of Endocrinology and Metabolism · doi:10.20945/2359-3997000000503 · Cited by 5 · see citing works

Adipose Tissue Dysfunction in Polycystic Ovary Syndrome

Villa, J., & Pratley, R. E. (2011) · Current Diabetes Reports · doi:10.1007/s11892-011-0189-8 · Cited by 130 · see citing works

Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome

Spritzer, P. M., Lecke, S. B., Satler, F., & Morsch, D. M. (2015) · Reproduction · doi:10.1530/rep-14-0435 · Cited by 330 · see citing works

The role of insulin and selected adipocytokines in patients with polycystic ovary syndrome (PCOS) – a literature review

Ożegowska, K., & Pawelczyk, L. A. (2015) · Ginekologia Polska · doi:10.17772/gp/2077 · Cited by 15 · see citing works

Adiposity and metabolic dysfunction in polycystic ovary syndrome

Sam, S. (2015) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2015-0008 · Cited by 26 · see citing works

Polycystic Ovary Syndrome as a Metabolic Disorder Involving Insulin Resistance, Chronic Inflammation and Adipose Dysfunction

Kamila, G. (2026) · Journal of chemical health risks